Intravenous Esomeprazole: A Pharmacoeconomic Profile of its Use in the Prevention of Recurrent Peptic Ulcer Bleeding

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.6, 2011-06, pp. : 535-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding

By Barkun Alan N.

PharmacoEconomics, Vol. 28, Iss. 3, 2010-03 ,pp. : 217-230

Adis International

Access to resources Recommend Favorite

IV esomeprazole cost effective in peptic ulcer bleeding

Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

IV esomeprazole cost effective in peptic ulcer bleeding

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 565, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Fixed-dose acetylsalicylic acid/esomeprazole: a guide to its use to prevent cardiovascular events and reduce peptic ulcer risk

By Lyseng-Williamson Katherine A. Burness Celeste B. Scott Lesley J.

Drugs & Therapy Perspectives, Vol. 28, Iss. 6, 2012-06 ,pp. : 10-14

Adis International

Access to resources Recommend Favorite

Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleeding

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1253-1256

Informa Healthcare

Access to resources Recommend Favorite